SPPI Financial Facts
Net income (loss): 20.26MTotal operating costs and expenses: 32.97M
See Full Income Statement
Property and equipment, net: 2.82M
Accounts payable and other accrued obligations: 50.05M
See Full Balance Sheet
Spectrum Pharmaceuticals (SPPI) Earnings
|
Expand Research on SPPI
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +9.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/11/22 | Q222 | N/A | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/17/22 |  |
Q421 | -$0.26 | -$0.21 | -$0.05 | $39.7K | N/A | N/A |  | | Details |
| 11/10/21 | |
Q321 | -$0.16 | -$0.28 | +$0.12 | N/A | $520K | N/A | | | Details |
| 8/12/21 | |
Q221 | -$0.25 | -$0.25 | $0.00 | N/A | N/A | N/A | | | Details |
| 5/13/21 | |
Q121 | -$0.25 | -$0.31 | +$0.06 | N/A | N/A | N/A | | | Details |
| 3/30/21 | |
Q420 | -$0.36 | -$0.29 | -$0.07 | N/A | N/A | N/A | | | Details |
| 11/4/20 | |
Q320 | -$0.27 | -$0.35 | +$0.08 | N/A | $50K | N/A | | | Details |
| 8/10/20 | |
Q220 | -$0.28 | -$0.32 | +$0.04 | N/A | $60K | N/A | | | Details |
